BeyondSpring Pharmaceuticals Inc.
6 clinical trials · Sponsor
◉ Watch BeyondSpring Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia (NCT03294577) | BeyondSpring Pharmaceuticals Inc. | 2019-10-23 |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 (NCT03102606) | BeyondSpring Pharmaceuticals Inc. | 2018-05-29 |
| Plinabulin iv Solution in Prevention of TAC Induced Neutropenia (NCT04227990) | BeyondSpring Pharmaceuticals Inc. | 2017-11-27 |
Track BeyondSpring Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.